請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/29306完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 楊偉勛 | |
| dc.contributor.author | I-Lin Wu | en |
| dc.contributor.author | 吳宜凌 | zh_TW |
| dc.date.accessioned | 2021-06-13T01:04:14Z | - |
| dc.date.available | 2007-08-08 | |
| dc.date.copyright | 2007-08-08 | |
| dc.date.issued | 2007 | |
| dc.date.submitted | 2007-07-23 | |
| dc.identifier.citation | Aitman TJ. Genetics medicine and obesity. N. Engl. J. Med. 2003; 348:2138-2139
Atsuko M, Kazuya Y, Masafumi K, et al. J Bio Chemistry 2006; 281(8):5246-5257 Banerji M, Lebovitz H. Insulin sensitive and insulin resistant variants in IDDM. Diabetes 1989; 38:784-792 Barrio R, Bellanne-Chantelot C, Moreno JC, et al. Nine novel mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families. J Clin Endocrinol Metab 2002; 87:2532-2539 Bingham C, Bulman MP, Ellard S, et al. Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease. Am J Hum Genet 2001; 68:219-224 Bogardus C, Lillioja S, Mott DM, et al. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol. 1985; 248:E286-E291 Byrne MM, Sturis J, Fajans SS, et al. Altered insulin secretory response to glucose in subjects with a mutation in the MODY 1 gene on chromosome 20. Diabetes 1995; 44: 699-704 Canter AB, Krischer JP, Cuthbertson DD, et al. Age and family relationship accentuate the risk of IDDM in relatives of patients with insulin dependent diabetes. J. Clin. Endocrinol. Metab. 1995; 80: 3739-3743 Cao H, Shorey S, Robinson J, et al. GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY). Hum Mutat 2002; 20:478-479 Carlos A. AS, Eduardo RR, et al. Early-Onset Type 2 Diabetes: Metabolic and Genetic Characterization in the Mexican Population. J Clin Endocrinol Metab 2001; 86 No1:220-226 Cecile H, Melanie F, Sarah C, et al. Severe pancreas hypoplasia and multicystic renal dysplasia in two human fetuses carrying novel HNF1beta/MODY5 mutations. HMG 2006 Carette C, Vaury C, Barthelemy A, et al. Exonic Duplication of the Hepatocyte Nuclear Factor-1{beta} Gene (Transcription Factor 2, Hepatic) as a Cause of Maturity Onset Diabetes of the Young Type 5. J Clin Endocrinol Metab 2007; 92(7):2844-2847 Duncan SA, Navas MA, Dufort D, et al. Regulation of a transcription factor network required for differentiation and metabolism. Science 1998; 281:692-695 Ewan RP, Sylvia FB, Anna MS, et al. Macrosomia and Hyperinsulinaemic Hypoglycaemia in Patients with Heterozygous Mutations in the HNF4A Gene. PLOS Medicine 2007; Vol 4 Issue 4 e118:001-0010 Fajans SS, Conn JW. Tolbutamide-induced improvement in carbohydrate tolerance of young people with mild diabetes mellitus. Diabetes 1960; 9: 83 Fajans SS. MODY: a model for understanding the pathogeneses and natural history of type II diabetes. Horm Metab Res 1987; 19: 591-599 Fajans SS, Brown B. Adminstration of sulfonylureas can increase glucose-induced insulin secretion for decades in patients with maturity- onset diabetes of the young. Diabetes Care 1993; 16: 1254-1261 Fajans SS, Bell GI, Bowden DW, et al. Maturity-onset diabetes of the young. Life Sci 1994; 55: 413-422 Fajans SS, Bell GI, Herman WH, et al. Natural history, genetics and pathogenesis of HNF-4α/MODY1: a 40-year prospective study of the RW pedigree. In: Matschinsky FM, Magnuson MA, eds. Vol. 15 of Frontiers in diabetes: molecular pathogenesis of MODYs. Basel, Switzerlan: Karger, 2000:1-15 Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001; 345:971-980 Frayling TM, Bulman MP, Appleton M, et al. A rapid screening method for hepatocyte nuclear factor 1 alpha frameshift mutations; prevalence in maturity-onset diabetes of the young and late-onset non-insulin dependent diabetes. Hum. Genet. 1997; 101:351-354 Frayling TM, Evans JC, Bulman MP, et al. β-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 2001; 50: S94-S100 Froguel P, Vaxillaire M, Sun F, et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 1992; 356:162-164 Gloyn AL. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Hum Mutat 2003; 22:353-362 Harper P, Clarke A. Should we test children for ‘adult’ genetic disease? Lancet 1990; 335:1205 Hattersley AT. Maturity-onset diabetes of the young: Clinical heterogeneity explained by genetics heterogeneity. Diabet. Med. 1998; 15:15-24 Helge R, Lise B, Stefan J, et al. A Hepatocyte Nuclear Factor-4α Gene (HNF4A) P2 Promoter Haplotype Linked With Late-Onset Diabetes. Diabetes 2006; 55:1899-1903 Herman WH, Fajans SS, Ortiz FJ, et al. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes 1994; 43: 40-46 Hertz R, Magenheim J, Berman I, et al. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature 1998; 392(6675):512-6 Huang W, Connor E, DelaRosa T, et al. Although DR3-DQB1 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1I0302 halotype is implicated only in beta cell autoimmunity. J. Clin. Endocrinol. Metab. 1996; 81:1-5 Jakob Ek, Sara PH, Maria L, et al. A Novel –192c/g Mutation in the Proximal P2 Promoter of the Hepatocyte Nuclear Factor-4α Gene (HNF4A) Associates With Late-Onset Diabetes. Diabetes 2006; Vol 55:1869-1873 Jap TS, Wu YC, Chiou JY, Kwok CF. A novel mutation in the hepatocyte nuclear factor-1α/MODY3 gene in Chinese subjects with early-onset Type 2 diabetes mellitus in Taiwan. Diabet. Med. 2000; 17: 390-393 Johansen A, Ek J, Mortensen HB, et al. Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK and TCF1. J Clin Endocrinol Metab 2005; 90(8):4607-4614 Jonsson J, Carlsson L, Edlund T, et al. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994; 371:606-609 Kristinsson SY, Thorolfsdottir ET, Talseth B. MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1. Diabetologia 2001; 44:2098-2103 Ledermann HM. Is maturity onset diabetes at young age(MODY) more common in Europe than previously assumed? Lancet 1995; 345(8950):648 Lindner TH, Njolstad PR, Horikawa Y, et al. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta. Hum Mol Genet 1999; 8:2001-2008 Lorna WH, Sian E, Amanda S, et al. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. Human Mol Genetics 2006; Vol 15 No.14:2216-2224 Martine V, Pharm D, Philippe F. Genetic basis of maturity-onset diabetes of the young. Endocrinol Metab Clin N Am 2006; 35:371-384 Milewski WM, Duguay SJ, Chan SJ, et al. Conservation of PDX-1 structure, function, and expression in zebrafish. Endocrinology 1998; 139:1440-1449 Neve B, Fernandez-Zapico ME, Ashkenazi-Katalan V, et al. Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function. Proc. Nat. Acad. Sci. 2005; 102: 4807-4812 Nishigori H, Yamada S, Kohama T, et al. Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction. Diabetes 1998; 47:1354-1355 Njolstad PR, Sagen JV, Bjorkhaug L, et al. Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway. Diabetes 2003; 52:2854-2860 Olefsky JM, Kolterman OG, Scarlett JA. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am. J. Physiol. 1982; 243:E15-E30 Parviz F, Matullo C, Garrison WD, et al. Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 2003; 34:292-296 Polonsky KS, Sturis J, Bell, GI. Non-insulin-dependent diabetes mellitus: a genetically programmed failure of the beta cell to compensate for insulin resistance. N. Engl. J. Med. 1996; 334: 777-784 Porter JR, Rangasami JJ, Ellard S, et al. Asian MODY: are we missing an important diagonosis? Diabetes UK 2006; 23:1257-1260 Raeder H, Johansson S, Holm PI, et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat Genet. 2006; 38(1):12-3.006 Rana KG, Marko ZV, Catherine SL, et al. The MODY1 gene HNF-4α regulates selected genes involved in insulin secretion. J Clin Invest 2005; Vol 115 No4:1006-1015 Shaat N, Karlsson E, Lernmark A, et al. Common variants in MODY genes increase the risk of gestational diabetes mellitus. Diabetologia 2006; 49:1545-1551 Shepherd M, Ellis I, Ahmad AM, et al. Predictive genetic testing in maturity-onset diabetes of the young (MODY). Diabetes UK 2001; 18:417-421 Shih DQ, Dansky HM, Fleisher M, et al. Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes 2000; 49:832-837 Sian E. Hepatocyte nuclear factor 1 alpha (HNF-1A) mutations in maturity-onset diabetes of the young. Human Mutation 2000; 16:377-385 Sian E, Kevin C. Mutation in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young. Human Mutation 2006; 27(9):854-869 Sovik O, Njolstad P, Folling I, et al. Hyperexcitability to sulphonylurea in MODY 3. Diabetologia 1998; 41: 607-608 Stefan SF, Graeme IB, Kenneth SP. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001; 345(13):971-980 Stoffel M, Duncan SA. The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism. Proc Natl Acad Sci USA 1997; 94:13209-13214 Stoffers DA, Ferrer J, Clarke WL, et al. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 1997; 17:138-9 Stoffers DA, Stanojevic V, Habener JF. Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein. J Clin Invest 1998; 102:232-241 Tamimi R, Steingrimsson E, Copeland NG. The NEUROD gene maps to human chromosome 2q32 and mouse chromosome 2. Genomics 1996; 34:418-421 Tattersall RB. Mild familial diabetes with dominant inheritance. Q. J. Med. 1974; 43: 339-357 Tattersall RB, Fajans SS. A difference between the inheritance of classical juvenile-onset and maturity-onset type of diabetes in young people. Diabetes 1975; 24:44-53 Tattersall R. Maturity-onset diabetes of the young: a clinical history. Diabet. Med. 1998; 15:11-14 Turner RC, Holman RR, Matthew D, et al. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative to contribution by feedback analysis from basal plasma insulin and glucose concentration. Metabolism 1979; 28: 1086-1096 Uusitupaa MIJ, Niskanen LK, Siitonen O, et al. Ten year cardiovascular mortality in relation to risk factors abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 1993; 18: 1534-1543 Velho G, Vaxillaire M, Boccio V, et al. Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q. Diabetes Care 1996; 19(9):915-9 Velho G, Benque-Blanchet F, Vaxillaire M, et al. Renal proximal tubular defects associated to the MODY3 phenotype. Diabetologia 1998; 41(S1):418 Wang H, Maechler P, Antinozzi PA, et al. Hepatocyte nuclear factor 4alpha regulates the expression of pancreatic beta-cell genes implicated in glucose metabolism and nutrient-induced insulin secretion. J Biol Chem 2000; 275:35953-35959 Wendy W, Robert RG, et al. Association Testing of Variants in the Hepatocyte Nuclear Factor 4α Gene With Risk of Type 2 Diabetes in 7883 People. Diabetes 2005; Vol 54: 886-892 Wright NM, Metzger DL, et al. Permanent neonatal diabetes mellitus and pancreatic exocrine insufficiency resulting from congenital pancreatic agenesis. Am J Dis Child 1993; 147:607-9 Xu J Y, Dan QH, Chan V, et al. Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients. Europ. J. Hum. Genet 2005; 13:422-427 Yamada S, Zhu Q, Aihara Y et al. Cloning of cDNA and the gene encoding human hepatocyte nuclear factor (HNF)-3β and mutation screening in Japanese subjects with maturity-onset diabetes of the young. Diabetologia 2000; 43: 121-124 Yamagata K. Regulation of pancreatic β-cell function by the HNF transcription netweek: Lessons from Maturity-Onset Diabetes of the Young (MODY). Endocrine Journal. 2003; 50: 491-499 | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/29306 | - |
| dc.description.abstract | 早發型糖尿病(maturity onset diabetes of the young, MODY)是一種自體顯性遺傳疾病，並已知至少有六個不同基因發生突變時會導致MODY發生。其中一個基因和醣解酵素(glucokinase, GCK)有關，此為MODY2，另外五個是和轉錄因子有關：hepatocyte nuclear factor (HNF)4α和MODY1相關，HNF1α和MODY3相關，HNF1β為MODY5，還有insulin promoter factor 1 (IPF-1)為MODY4，及neurogenic differentation factor 1 (NeuroD1)為MODY6。這些突變皆可導致β細胞功能不全及糖尿病。MODY病人和其他第2型糖尿病人間有些不同的臨床表徵，包括有：MODY至少有二代或是更多代之間是具有明顯的家族史、在年紀輕時就有病徵及非肥胖型。本篇研究目的，是欲了解台灣MODY家族的遺傳型態，建立台灣MODY病人的基因型，並能藉此將對於MODY病人的遺傳諮詢模式做一探討。目前收集了一案例，其家族中兩代共有四位罹病者，將未檢測的GCK、HNF4α、HNF1β及IPF-1四個基因之exons做PCR和定序，另外，已知HNF1α基因之exon 9中的一胺基酸改變，在正常人中亦做PCR和定序，但這些基因檢測中，並無發現任何特定或有意義的突變是和MODY的發生有相關，且過去找到的HNF1α基因中之突變亦在正常人中發現，故此應為單一核苷酸多型性。本文個案完成目前已知和MODY相關之基因檢測，且在MODY疾病之遺傳諮詢部分，擬定其基因檢測同意書並探討與設立預測性基因檢測之流程，對於台灣MODY疾病的研究與診斷MODY亞型的模式有一完整的開端，未來可望能再進一步朝其他和胰臟功能或是胰島素分泌相關基因來做分析或檢測。 | zh_TW |
| dc.description.abstract | Maturity onset diabetes of the young (MODY) is a autosomal dominant inheritance disease and the six subtypes are caused by six different genes.
The glucokinase (GCK) is associated with MODY 2. The others are transcription factors: hepatocyte nuclear factor-4α (HNF-4α, MODY1), HNF-1α (MODY3), HNF-1β (MODY5), insulin promoter factor 1 (IPF-1, MODY4) and neurogenic differentation factor 1 (NeuroD1, MODY6). The mutations of all these genes lead to the pancreatic β-cell dysfunction and diabetes. The difference in clinical phenotypes between MODY and type 2 diabetes are the transmission of diabetes through at least two generations in a family, ideally two family members diagnosed before 25 years unlike type 2 diabetes, MODY is rarely associated with obesity. Our aim was to initiate a genetic diagnosis and counseling protocol in Taiwan. The case is one of four MODY patients in two generations in the family. Previously, we have examined the HNF-1α and NeuroD1. Thus, the coding regions with intron-exon site of four other genes including GCK, HNF-4α, HNF-1β and IPF-1 were examined by polymerase chain reaction (PCR) and direct sequencing. Besides, four normal elderly control were tested for the mutation found in the exon 9 of HNF-1α before by PCR and direct sequencing. There is no novel mutation within these genes. It is important to set up the format for genetic testing and genetic counseling for MODY in Taiwan. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T01:04:14Z (GMT). No. of bitstreams: 1 ntu-96-P94448009-1.pdf: 947941 bytes, checksum: 4b1ff6e65d743a9350fc315c458fd7c7 (MD5) Previous issue date: 2007 | en |
| dc.description.tableofcontents | 摘要………………………………………………………………………4
Summary………………………………………………………………….5 目錄…..…………………………………………………………………...6 前言 糖尿病簡介………………………………………………………….8 MODY緒論……………………………………................................9 MODY臨床表現…………………………………….......................10 MODY相關基因……………………………………………….......11 預測性基因檢測…………………………………………………….18 研究動機………………………………………………………………....20 實驗材料………………………………………………………………....21 實驗方法………………………………………………………………....23 結果……………………………………………………………………....26 討論……………………………………………………………………....29 參考文獻………………………………………………………………....32 圖 圖1 研究個案家族………………………………………………26 圖2 HNF4α exon9 定序結果……………….…………………..48 表 表1 MODY與第二型糖尿病臨床特徵…………………….…..39 表2 MODY亞型及相關基因……………….…………………..40 表3 HNF1α之檢測結果………………………………………....41 表4 GCK primer sequences及PCR之Tm值…………...……...42 表5 HNF1-β primer sequences及PCR之Tm值……………….43 表6 HNF4-α primer sequences及PCR之Tm值……………….44 表7 IPF1 primer sequences及PCR之Tm值…………………..45 表8 HNF1-α primer sequences…………………………………...46 表8-1 HNF1-α PCR condition……………………………………..46 表9 GCK 及HNF1-β之SNP…………………………………...47 附錄1：MODY診斷性基因檢測知情同意書………………………...49 附錄2：MODY預測性基因檢測同意書……………………………...53 | |
| dc.language.iso | zh-TW | |
| dc.title | 建立台灣年輕型糖尿病遺傳諮詢之模式 | zh_TW |
| dc.title | Establish The Mode of The Genetic Counseling in
Maturity-Onset Diabetes of The Young in Taiwan | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 95-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 賴凌平,蘇怡寧 | |
| dc.subject.keyword | 年輕型糖尿病,胰島素,遺傳諮詢,醣解酵素,轉錄因子, | zh_TW |
| dc.subject.keyword | Maturity onset diabetes of the young,insulin,genetic counseling,glucokinase,transcription factor, | en |
| dc.relation.page | 50 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2007-07-24 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 分子醫學研究所 | zh_TW |
| 顯示於系所單位： | 分子醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-96-1.pdf 目前未授權公開取用 | 925.72 kB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。